Monday, November 5, 2012

• Cyclacel receives $1.9M translational medicine grant award for CYC065theflyonthewall.com (Mon, Nov 5)

Thursday, October 25, 2012

• 4 Biotech Stocks Under $10 Moving Higherat TheStreet (Thu, Oct 25)

Wednesday, October 24, 2012

• Why These 3 Biotech Stocks Are Winningat Motley Fool (Wed, Oct 24)

Tuesday, October 23, 2012

• Possible Reverse Split Should Be The Catalyst Needed To Take NeoStem Shares Higherat Seeking Alpha (Tue, Oct 23)

Monday, October 22, 2012

• Biotech Weekend Recap: Bears, Bears Everywhereat Seeking Alpha (Mon, Oct 22)

Wednesday, October 17, 2012

• How to Prep for the Inevitable Bursting of the Biotech Stock Bubbleat TheStreet (Wed, Oct 17)

Tuesday, October 16, 2012

• Cyclacel Heats Up On Clinical Trial Progressionat Seeking Alpha (Tue, Oct 16)
• Conagra Estimates FY13 Cash Flow and 4 Stocks that Have Hit 52-Week Highsat Wall St. Cheat Sheet (Tue, Oct 16)

Monday, October 15, 2012

• Verizon Begins Idearc Lawsuit and 4 Hot Stocks Buzzing Nowat Wall St. Cheat Sheet (Mon, Oct 15)
• The Nasdaq Now: Clearwire Basks in Softbank-Sprint Deal Haloat Minyanville (Mon, Oct 15)

Friday, October 12, 2012

• Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint VenturesMarketwired (Fri, Oct 12)

Monday, October 8, 2012

• Can a Reverse Split Reverse the Trend?at Motley Fool (Mon, Oct 8)

Wednesday, September 26, 2012

• 2.4% Yield And 10+ Potential Blockbuster Drugsat Seeking Alpha (Wed, Sep 26)

Monday, September 24, 2012

• Faster FDA Review Process a Contributing Factor to Biotech Industry's Rise in 2012Marketwired (Mon, Sep 24)

Friday, September 21, 2012

• Biotech Stock Mailbag: Pending Sarepta Results, Cyclacelat TheStreet (Fri, Sep 21)

Thursday, September 20, 2012

• Ophir Shahaf, Chief Executive Officer of Hadasit Bio-Holdings Ltd. (HADSY): a Wall Street Transcript InterviewWall Street Transcript (Thu, Sep 20)

Wednesday, September 19, 2012

• Biotech Stock Live Chat: Fall Previewat TheStreet (Wed, Sep 19)

Tuesday, September 18, 2012

• Wall Street Transcript Interview with Cyclacel Pharmaceuticals, Inc. (CYCC) President and Chief Executive Officer Spiro RombotisWall Street Transcript (Tue, Sep 18)

Thursday, September 13, 2012

• CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Thu, Sep 13)

Tuesday, September 11, 2012

• 4 Biotech Stocks Under $10 Making Big Movesat TheStreet (Tue, Sep 11)

Thursday, August 30, 2012

• 4 Cash Loaded Biotech Stocks With Little Debtat Seeking Alpha (Thu, Aug 30)

Friday, August 24, 2012

• CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments toEDGAR Online (Fri, Aug 24)

Monday, August 20, 2012

• 5 Pharmaceutical Companies With Phase III Clinical Study Catalysts This Year - Part IVat Seeking Alpha (Mon, Aug 20)

Tuesday, August 14, 2012

• Cyclacel Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Aug 14)
• CYCLACEL PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementEDGAR Online (Tue, Aug 14)

Add CYCC News to My Yahoo!